UAVS heads into its May 21 earnings call carrying a sharp contradiction: fresh US Army contract wins on one side, a steep Q1 revenue decline on the other.
The headline from yesterday's Q1 filing said it all — sales came in at $1.4 million, down from $3.65 million a year earlier. That is a 62% year-on-year drop. The company, which rebranded operationally as EagleNXT, moved quickly to cushion the blow. A same-day shareholder update flagged three new US Army contract awards secured at the start of Q2, plus the opening of a Texas facility. Management's message is that Q1 was a trough and Q2 momentum is already building. The market's reaction was less charitable — the stock closed at $1.05 on Friday, down 10.3% on the week.
Short positioning has been the more telling signal this week. Bears rebuilt meaningfully after a quiet spell, with SI % FF climbing from roughly 4.3% to 5.3% over the five trading days through May 14. That is a 13% jump in shorted shares in one week alone, reversing a month-long unwinding from the late-April high of nearly 6.9%. The rebuild arrived almost exactly as the Q1 filing hit. It tells a clear story: shorts who had been covering into April saw fresh reason to re-engage once the revenue miss became official.
The borrow market, however, does not look stressed. Availability has loosened considerably from the squeeze conditions seen in mid-April, when the lending pool was nearly fully used at above 97% utilization and cost to borrow reached 4.5%. CTB has since fallen sharply to around 1.44% — less than a third of that peak level. Availability is no longer anywhere near its tightest, suggesting the new short interest coming in this week found plenty of room in the lending pool. That is a notable contrast: shorts are re-engaging, but the borrow market is not under pressure.
Factor scores offer limited comfort for bulls. ORTEX's total stock score puts UAVS in the bottom third of the universe at around 32 out of 100. Momentum, quality, and value sub-scores are all modest. The short score of 52, while mid-range in absolute terms, has held stubbornly around that level all week — consistent with the positioning rebuild rather than a clean directional shift in either direction. There is no meaningful analyst coverage to lean on, and with a market cap that has now slipped below measurable levels in public data, institutional sponsorship is thin: Vanguard's passive holding at 2.9% is the largest single institutional position.
Insiders have been net buyers over the past several months. The Chairman purchased shares three separate times between August and November 2025, and the CEO added small amounts in September. Those trades came at prices between $1.73 and $1.92 — all above the current $1.05 close. The consistency of the buying cluster is notable, though the dollar amounts were modest (under $30,000 per transaction), and the most recent trade was in mid-November. Whether that insider floor holds as the price tests new lows is one of the dynamics to track around the May 21 call.
Looking at the prior three earnings reactions, UAVS has a pattern of positive one-day pops — gains of 7.7%, 5.9%, and 5.5% respectively. The five-day follow-through, however, has been mixed, with one episode giving back nearly 9.5% after the initial bounce. The next earnings print will be less about whether contracts are being won — Army awards are now confirmed — and more about whether Q2 revenue is materialising fast enough to justify a rebound narrative at current short levels.
See the live data behind this article on ORTEX.
Open UAVS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
